Successful liver transduction by re‐administration of different adeno‐associated virus vector serotypes in mice

Background Intravenous administration of adeno‐associated virus (AAV) vectors is a promising gene therapy approach for monogenic diseases. However, re‐administration of the same AAV serotype is impossible because of the induction of anti‐AAV neutralizing antibodies (NAbs). Here, we examined the feas...

Ausführliche Beschreibung